Table of Contents

company-logo

Altamira Therapeutics Ltd. engages in developing therapeutics that address various unmet medical needs. Its commercial products include Bentrio, a drug-free nasal spray for personal protection against airborne viruses and allergens. The company is also involved in the development of RNA therapeutics for extrahepatic therapeutic targets, including OligoPhore and SemaPhore platforms that are in preclinical stage for oligonucleotide and mRNA delivery; AM-125 that is in phase II clinical trial for the intranasal treatment of vertigo; Keyzilen, which is in phase III clinical trial for the treatment of acute inner ear tinnitus; and Sonsuvi that is in phase III of clinical development for the treatment of acute inner ear hearing loss. It operates in Switzerland, the United States, Europe, and Australia. The company was formerly known as Auris Medical Holding Ltd. and changed its name to Altamira Therapeutics Ltd. in July 2021. Altamira Therapeutics Ltd. was founded in 2003 and is headquartered in Hamilton, Bermuda.

Altamira Therapeutics Dividend Announcement

• Altamira Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Altamira Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Altamira Therapeutics Dividend History

Altamira Therapeutics Dividend Yield

Altamira Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Altamira Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Altamira Therapeutics Financial Ratios

P/E ratio-0.03
PEG ratio0.00
P/B ratio0.03
ROE783.37%
Payout ratio0.00%
Current ratio1.38
Quick ratio1.46
Cash Ratio0.69

Altamira Therapeutics Dividend FAQ

Does Altamira Therapeutics stock pay dividends?
Altamira Therapeutics does not currently pay dividends to its shareholders.
Has Altamira Therapeutics ever paid a dividend?
No, Altamira Therapeutics has no a history of paying dividends to its shareholders. Altamira Therapeutics is not known for its dividend payments.
Why doesn't Altamira Therapeutics pay dividends?
There are several potential reasons why Altamira Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Altamira Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Altamira Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Altamira Therapeutics a dividend aristocrat?
Altamira Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Altamira Therapeutics a dividend king?
Altamira Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Altamira Therapeutics a dividend stock?
No, Altamira Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Altamira Therapeutics stocks?
To buy Altamira Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Altamira Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.